C

Clinical Laserthermia Systems
CLS B

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
SEK98.69M
EV
SEK68.24M
Shares Outstanding
25.67M
Beta
-0.00

Wall Street View

Analyst Rating
NO_OPINION
Analyst Target Price
SEK12.00
P/E 2025E
-
P/Revenue 2025E
2.70x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Clinical Laserthermia Systems AB (publ)

gainify

C

Clinical Laserthermia Systems AB (publ)

CLS B

Clinical Laserthermia Systems AB (publ) engages in the development of treatment tools for diseased tissue under the TRANBERG brand in Sweden. It offers TRANBERG, a thermal therapy system designed to deliver laser energy to heat the target tissue. The company also prov...

Sector

Healthcare

Industry

Medical - Devices

CEO

Mogren, Dan

Employees

17

IPO Date

2009-04-16

Headquarters

Building 405, ScheelevAegen 2, Lund, Skåne County, 223 81 Sweden

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.